Celexor Bio Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 1

Celexor Bio General Information

Description

Developer of a robust therapeutic drug intended to transform the treatment of severe, underserved autoimmune and inflammatory disorders. The company offers treatment of pDC-driven autoimmune diseases to limit inflammation and immune response to minimize symptoms, enabling healthcare professionals to improve patient outcomes and go beyond symptomatic treatment and modify the course of disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1111 Broadway
  • Suite 1300
  • Oakland, CA 94607
  • United States
+1 (510)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 1111 Broadway
  • Suite 1300
  • Oakland, CA 94607
  • United States
+1 (510)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celexor Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 21-Sep-2023 Completed Startup
To view Celexor Bio’s complete valuation and funding history, request access »

Celexor Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2
Seed-1
To view Celexor Bio’s complete cap table history, request access »

Celexor Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aditum Bio Venture Capital Minority
To view Celexor Bio’s complete investors history, request access »

Celexor Bio FAQs

  • When was Celexor Bio founded?

    Celexor Bio was founded in 2023.

  • Where is Celexor Bio headquartered?

    Celexor Bio is headquartered in Oakland, CA.

  • What industry is Celexor Bio in?

    Celexor Bio’s primary industry is Drug Discovery.

  • Is Celexor Bio a private or public company?

    Celexor Bio is a Private company.

  • What is Celexor Bio’s current revenue?

    The current revenue for Celexor Bio is .

  • Who are Celexor Bio’s investors?

    Aditum Bio has invested in Celexor Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process